Genmab — December 2019

[GeorgeBest]

Vil næste opdatering være på ASCO?

[E_L]

excellent Helge

[E_L]

lol GB, haven't even heard the R&D yet and already looking for the next

[mobbyduck1]

lol

[Solsen]

They note that MTD are not reached at 12 mg. We look fw to ASCO.

[Bulder]

23,7$=1601dkk

[GeorgeBest]

EL - I am long term investor and very impatient...;-)

[Bulder]

gmab.us responding nicely 23,79$

[Bulder]

I guess this is what we were looking for

[Helge_LarsenPI-redaktør]

Rigth now. Guest in our chat from Denmark, Sweden, Norway, Netherland, Belgium (David and friends), Finland, Jersey, Lithuania, Luxembourg, South Africa, US, GB and Switzerland.

[Bulder]

oh I love Swiss cheese

[Helge_LarsenPI-redaktør]

And now Spain and Hungary.

[transalp]

+24$ nu..

[bibob]

Ok Helge. So Denmark are the center in the World right now.

[E_L]

vd Winkel had toxicity as his main concern due to the high potency, so I am very
happy with this; i was a bit worried tbh...

[Bulder]

agree

[bibob]

Træls for dem som solgte i 1575.

[Bulder]

close in 24,01$ = 1622 dkk

[Bulder]

Let's see if the R&D update can add a little to this

[Helge_LarsenPI-redaktør]

Safety is important. Hope that potential partners can understand that the basics must be in order before dose scaling. Like when Plesner started in 2007 with daratumumab in almost homeopathic form.